Estudo JAVELIN Ovarian 100 avalia o uso de avelumabe no tratamento

Estudo publicado no The New England Journal of Medicine avalia o papel terapêutico do avelumabe (anticorpo anti-PD-L1) em diferentes combinações no tratamento do câncer de ovário.

ASCO 2022: Long-Term Outcomes in Patients with Advanced Urothelial

Arquivos Câncer - Página 9 de 64 - Oncologia Brasil

Chemotherapy with or without avelumab followed by avelumab

ASCO 2023: Long-Term Safety of Avelumab First-Line Maintenance for

PDF) Medicina: Longe dos holofotes, perto das pessoas 2 (Atena

PDF) Marcos Santos Mônica Nonato

ASCO 2020: JAVELIN Bladder 100 Phase III Results: Maintenance

O que muda no MOC após a ASCO 2020 - Manual de Oncologia Clínica

Avelumab first-line maintenance plus best supportive care (BSC) vs

ASCO 2022: Avelumab First-Line (1L) Maintenance for Advanced

ASCO GU 2023: Avelumab First-Line Maintenance for Advanced

JAVELIN Bladder 100 Trial TE Articles

JAVELIN Bladder 100 Long-term Results: Avelumab Maintenance